Tomokazu Souma

3.5k citations
40 papers · 2.1k indexed · h-index 23
Topics
Renal and related cancers (7 papers)Erythropoietin and Anemia Treatment (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)
Partner nations
United StatesJapanCanada

In The Last Decade

Tomokazu Souma

39 papers receiving 2.0k citations

Peers

Tomokazu Souma
Comparison fields: 5 of 114
  • Molecular Biology 822
  • Nephrology 330
  • Hematology 317
  • Cancer Research 311
  • Pulmonary and Respiratory Medicine 242
Replace Guie Dong with:
Guie Dong United States
Shuji Hamazaki Japan
Mindy Zhang United States
Natascha A. Wolff Germany
Subhashini Bolisetty United States
Christian Wadsack Austria
Anja Verhulst Belgium
Kwon Moo Park South Korea
Amie Traylor United States
Tomokazu Souma relative to Guie Dong United States Guie Dong's profile →
Citations per field
00.5×10×
Guie Dong · 1×
Citations per year

Countries citing papers authored by Tomokazu Souma

Since Specialization
Citations

This map shows the geographic impact of Tomokazu Souma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomokazu Souma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomokazu Souma more than expected).

Fields of papers citing papers by Tomokazu Souma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomokazu Souma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomokazu Souma. The network helps show where Tomokazu Souma may publish in the future.

Co-authorship network of co-authors of Tomokazu Souma

This figure shows the co-authorship network connecting the top 25 collaborators of Tomokazu Souma. A scholar is included among the top collaborators of Tomokazu Souma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomokazu Souma. Tomokazu Souma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 7
4 5
5 42
6 18
7 105
8 27
9 134
10 24
11 39
12 9
13 182
14 31
15 71
16 2
17 17
18 129
19 21
20 28

About Tomokazu Souma

Tomokazu Souma is a scholar working on Nephrology, Transplantation and Hematology, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), Erythropoietin and Anemia Treatment (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Nephrology (330 citations), Clinical Biochemistry (231 citations) and Hematology (317 citations). Tomokazu Souma has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Masayuki Yamamoto, Norio Suzuki, Sadayoshi Ito, Masahiro Nezu, Ikuo Hirano, Shun Yamazaki, Lei Yu, L. Ebony Boulware, John W. Stanifer and Xinlu Zhao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026